Hormonal therapy in breast cancer: A model disease for the personalization of cancer care
Author:
Publisher
Wiley
Subject
Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology
Reference112 articles.
1. Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741;Abrams;Journal of Clinical Oncology,1999
2. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea - a report from the Korean Breast Cancer Society;Ahn;Journal of Clinical Oncology,2007
3. No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6 inhibiting medications;Ahren;Cancer Epidemiology Biomarkers & Prevention,2009
4. Prognostic and predictive value of the 21-gene recurrence score assay in post-menopausal women with node-positive, estrogen-receptor-positive breast cancer on chemotherapy; a retrospective analysis of a randomized trial;Albain;The Lancet Oncology,2010
5. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: systematic review and meta-analysis;Amir;Journal of the National Cancer Institute,2011
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Estrogen receptor alpha (ER-α) antagonistic activity of phytoconstituents from Potentilla atrosanguinea and Potentilla fulgens in breast cancer;Fitoterapia;2024-09
2. Impact of HDAC6-mediated progesterone receptor expression on the response of breast cancer cells to hormonal therapy;European Journal of Pharmacology;2024-09
3. Staphylococcus Epidermidis Biofilm in Inflammatory Breast Cancer and Its Treatment Strategies;Biofilm;2024-09
4. Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models;Clinical Cancer Research;2024-05-31
5. Redox-Sensitive Poly(lactic-co-glycolic acid) Nanoparticles of Palbociclib: Development, Ultrasound/Photoacoustic Imaging, and Smart Breast Cancer Therapy;Molecular Pharmaceutics;2024-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3